Medically Supervised Management for Fatty Liver (NAFLD/MASLD) in South Delhi.
Metabolic Recomposition Programme
Nearly one in three Indian adults has fatty liver disease — and most have no idea, because it is silent until it isn't. Recompose Health treats fatty liver as what it actually is: a metabolic condition, not a standalone liver problem. We track it with Fibroscan, not guesswork.
Physician-Led Programme
Fibroscan-Backed Tracking
Monthly Lab-Backed Reports
Greater Kailash I, New Delhi
Fatty liver disease — now more accurately called MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), and previously known as NAFLD — is one of the most under-diagnosed conditions in urban India. It is closely linked to obesity, insulin resistance, and Type 2 diabetes, and the data shows North India carries one of the highest burdens in the country. Most people discover it incidentally on a routine ultrasound, with no symptoms and no follow-up plan.
Standard ultrasound can tell you that fat is present in the liver, but it cannot tell you whether scarring has begun or how severe it is. At Recompose Health in Greater Kailash I, every patient's fatty liver is staged with Fibroscan — measuring liver stiffness (fibrosis) and the CAP score (fat content) — and treated as part of your full metabolic picture, alongside blood sugar, weight, and lipid profile, not in isolation.
Fatty Liver Found on Ultrasound
A routine scan flagged "mild fatty liver" or "grade 1/2 hepatic steatosis" and no one explained what to do next.
Elevated Liver Enzymes
Raised ALT, AST, or GGT on a routine blood test, with no clear explanation given.
Obesity, Diabetes or High Triglycerides
Any of the core metabolic risk factors that make fatty liver far more likely, with or without a diagnosis yet.
Want to Know If It's Progressing
You were diagnosed years ago and have never had your liver staged with Fibroscan to know where you actually stand.
Most fatty liver care in Delhi happens once, inside a hospital department. We track it every month, in one continuous programme.
Fibroscan, Not Just Ultrasound
We measure liver stiffness and fat content directly, replacing guesswork with an objective number you can track over time.
Treated as a Metabolic Condition
Your liver markers are reviewed alongside HbA1c, weight, and lipids — because fatty liver almost never travels alone.
A Dedicated Care Coordinator
Your care coordinator tracks every lab and scan, flags abnormal results, and personally checks in if you go quiet.
The Monthly Combined Report
A single visual report tracking liver enzymes, Fibroscan trends, weight, and metabolic markers together — shared with you every month.
True Multidisciplinary Care
A metabolic physician, dietician, and psychologist working from one shared plan — the same depth of care major hospitals reserve for their liver units, in a boutique setting.
WhatsApp-Native Journey
Weekly check-ins, dietary nudges, and your monthly report — delivered where you already are.
1 | Discovery Consultation A full clinical assessment reviewing your existing scans, liver enzymes, BMI, sugar history, and lifestyle factors. We place you in the right treatment tier and explain pricing transparently. |
2 | Baseline Labs, Fibroscan & Onboarding Liver function, HbA1c, fasting glucose, full lipid panel, kidney function, and a Fibroscan to stage your liver stiffness and fat content. You are added to your private WhatsApp care journey. |
3 | Treatment Initiation A structured plan addressing the underlying drivers — weight, blood sugar, and lipids — alongside your first dietician and psychologist sessions. GLP-1 therapy considered where clinically indicated. Weekly check-ins begin immediately. |
4 | Monthly Metabolic Checks Repeat labs and your first Monthly Combined Specialist Report — tracking liver enzymes, weight, and metabolic markers together, in one document. |
5 | Consolidation, Repeat Fibroscan & Long-Term Handoff A repeat Fibroscan to objectively compare liver stiffness and fat content against your baseline, final labs, and a structured handoff into long-term metabolic maintenance. |
Lead Physician
Metabolic assessment, GLP-1 consideration where indicated, dose titration, and interpretation of every lab and Fibroscan.
Respiratory & Sleep Specialist
Sleep apnoea assessment and respiratory comorbidity management, frequently co-occurring with fatty liver.
Dedicated Dietician
Monthly sessions building a liver-friendly eating plan low in refined carbohydrates and saturated fat, tailored to your labs.
Clinical Psychologist
Behavioural support for sustaining dietary and lifestyle change over months, not just a one-time consult.
Every tier is physician-led. The right one depends on your Fibroscan stage, BMI, and comorbidities — we will help you decide at your discovery consult.
Essential
3-Month Programme
For early or simple fatty liver with low comorbidity burden. Includes physician consults, baseline labs, and monthly dietician sessions to address the lifestyle drivers directly.
Most Chosen
Advanced
6-Month Programme
For fatty liver with obesity or diabetes and one or two comorbidities. Adds GLP-1 medication management where indicated, psychologist support, and DEXA body composition tracking.
Precision
8-Month Programme
For more advanced fibrosis stages, multiple comorbidities, or complex obesity. Adds repeat Fibroscan, monthly specialist concalls, full organ monitoring, and the complete Combined Specialist Report suite.
GLP-1 and other medication, where prescribed, is billed separately. Exact pricing is shared transparently at your discovery consultation.
Liver Markers
ALT, AST, GGT, and Fibroscan liver stiffness (kPa) and CAP fat score (dB/m), tracked across the programme.
Metabolic Drivers
HbA1c, fasting glucose, and full lipid panel — the upstream factors that drive fatty liver progression.
Body Composition
Weight, BMI, waist circumference, and DEXA visceral fat — the strongest predictor of liver fat accumulation.
Recompose Health
Greater Kailash I, Greater Kailash, New Delhi, Delhi 110048
Book a discovery consultation to get a full clinical assessment, Fibroscan-backed staging, and transparent pricing — no obligation, no medication-first sales pitch.
Fatty liver disease (NAFLD/MASLD) is a clinical diagnosis that should be confirmed and staged by a qualified physician using appropriate imaging and blood tests. There is currently no single medication universally approved for fatty liver in India; treatment is directed at the underlying metabolic drivers under physician supervision. GLP-1 receptor agonist therapy, where used, is prescription-only and initiated only after comprehensive medical evaluation. Individual results vary based on disease stage, adherence, and clinical assessment. This page is for informational purposes and does not constitute medical advice.
We've compiled a list of the most frequently asked questions to help you find the information you need quickly and easily.
